1Hamm CW, Bassand JP, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J, 2011,32: 2999-3054.
2Giugliano RP, Sabatine MS, Gibson CM, et al. Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusion. Am J Cardiol, 2004, 93 : 1362-1367.
3Schrtider R. Prognostic impact of early ST-segment resolution in acute ST-elevation myocardial infarction. Circulation, 2004, 110 : c506-510.
4TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. N Engl J Med, 1985, 312:932-936.
5Gibson CM,Cannon CP, Daley WL, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation, 1996, 93:879-888.
6Gibson CM, Cannon CP, Murphy SA, et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation, 2000, 101 : 125-130.
7van't HofAW,Liem A, Suryapranata H, et al. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade : Zwolle Myocardial Infarction Study Group. Circulation, 1998, 97 : 2302-2306.
8Ding S,Pu J, Qiao ZQ, et al. TIMI myocardial perfusion frame count: a new method to assess myocardial perfusion and its predictive value for short-term prognosis. Catheter Cardiovasc Interv, 2010. 75:722-732.
9Korosoglou G, Haars A, Michael G, et al. Quantitative evaluation of myocardial blush to assess tissue level reperfusion in patients with acute ST-elevation myocardial infarction : incremental prognostic value compared with visual assessment. Am Heart J, 2007, 153:612-620.
10Shen LH,Wan F, Shen L, et al. Pharmacoinvasive therapy for ST elevation myocardial infarction in China: a pilot study. J Thromb Thrombolysis, 2012, 33 : 101-108.
2O'Gara PT,Kushner FG,Ascheim DD,et al.2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction:executive summary:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.J Am Coll Cardiol,2013,61(4):485-510.
3Taylor J.2012 ESC Guidelines on acute myocardial infarction(STEMI).Eur Heart J,2012,33(20):2501-2502.
4Levine GN,Bates ER1,Blankenship JC,et al.2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction:An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction:A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.Circulation,2016,133(11):1135-1147.
5Kristensen SD,Laut KG,Fajadet J,et al.Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011:current status in 37 ESC countries.Eur Heart J,2014,35(29):1957-1970.
6Al-Zakwani I,Zubaid M,Al-Riyami A,et al.Primary coronary intervention versus thrombolytic therapy in myocardial infarction patients in the Middle East.Int J Clin Pharm,2012,34(3):445-451.
7Kunadian V,Gibson CM.Thrombolytics and myocardial infarction.Cardiovasc Ther,2012,30(2):e81-e88.
8Fletcher AP,Alkjaersig N,Smyrniotis FE,et al.The treatment of patients suffering from early myocardial infarction with massive and prolonged streptokinase therapy.Trans Assoc Am Physicians,1958,71:287-296.
9Chazov EI,Matveeva LS,Mazaev AV,et al.Intracoronary administration of fibrinolysin in acute myocardial infarct.Ter Arkh,1976,48(4):8-19.
10Rentrop KP,Blanke H,Karsch KR,et al.Acute myocardial infarction:intracoronary application of nitroglycerin and streptokinase.Clin Cardiol,1979,2(5):354-363.
